Author

R. Tellier

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

A. B. Cortot· 1 shared A. Laratte· 1 shared A. Vinchent· 1 shared C. Descarpentries· 1 shared C. M. Guerin· 1 shared C. Villenet· 1 shared D. Tulasne· 1 shared E. Rouleau· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. B. Cortot

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

MET variants with activating N-lobe mutations identified in hereditary papillary renal cell carcinomas still require ligand stimulation

C. M. Guerin, A. Vinchent, M. Fernandes, I. Damour, A. Laratte, R. Tellier, G. O. Estevam, J.-P. Meneboo, C. Villenet, C. Descarpentries, J. S. Fraser, M. Figeac, A. B. Cortot, E. Rouleau, D. Tulasne

This paper identifies N-lobe MET mutations in HPRCC that require ligand stimulation for activation, unlike kinase domain mutations, and shows their sensitivity to MET inhibitors.

bioRxiv · Nov 3, 2023Cancer Biology